Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease
Background. Obesity is a barrier to transplant, reducing access and leading to worse outcomes versus nonobese adults. Most transplant centers in the United States maintain body mass index (BMI) cutoffs to listing for kidney transplantation of 35 to 40 kg/m2. There is little contemporary data on the...
Guardado en:
Autores principales: | Glenn K. Wakam, MD, Kyle H. Sheetz, MD, MS, Laura Gerhardinger, MA, John R. Montgomery, MD, Seth A. Waits, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10ad4e6e95bf40c78d66ba1645650ae6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Case Report: Absence of Clinically Significant Recurrent Diabetic Kidney Disease on Postmortem Biopsy 32 Years After Kidney Transplantation for Type 1 Diabetes
por: David D. M. Nicholl, MD, MS, et al.
Publicado: (2021) -
SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
por: Dominique Bertrand, MD, et al.
Publicado: (2021) -
Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
por: Mario Fernández-Ruiz, MD, PhD, et al.
Publicado: (2021) -
Acute on Chronic Liver Failure: Factors Associated With Transplantation
por: Naeem Goussous, MD, et al.
Publicado: (2021) -
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Christopher J. Mowry, MD, et al.
Publicado: (2021)